Cybin, Inc. (HELP)
12.37
-1.65
(-11.77%)
USD |
NASDAQ |
Sep 18, 16:00
12.64
+0.27
(+2.18%)
Pre-Market: 08:59
Cybin Enterprise Value : 600.38M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 600.38M |
| September 17, 2026 | 702.65M |
| September 16, 2026 | 668.56M |
| September 15, 2026 | 646.87M |
| September 14, 2026 | 677.24M |
| September 11, 2026 | 637.57M |
| September 10, 2026 | 629.51M |
| September 09, 2026 | 681.58M |
| September 08, 2026 | 601.62M |
| September 04, 2026 | 591.08M |
| September 03, 2026 | 563.19M |
| September 02, 2026 | 574.34M |
| September 01, 2026 | 552.65M |
| August 31, 2026 | 562.57M |
| August 28, 2026 | 588.60M |
| August 27, 2026 | 654.30M |
| August 26, 2026 | 678.48M |
| August 25, 2026 | 700.48M |
| August 24, 2026 | 640.67M |
| August 21, 2026 | 614.01M |
| August 20, 2026 | 606.58M |
| August 19, 2026 | 563.81M |
| August 18, 2026 | 556.99M |
| August 17, 2026 | 550.79M |
| August 14, 2026 | 576.82M |
| Date | Value |
|---|---|
| August 13, 2026 | 543.35M |
| August 12, 2026 | 545.83M |
| August 11, 2026 | 459.05M |
| August 10, 2026 | 454.10M |
| August 07, 2026 | 553.27M |
| August 06, 2026 | 521.66M |
| August 05, 2026 | 486.33M |
| August 04, 2026 | 408.85M |
| August 03, 2026 | 333.23M |
| July 31, 2026 | 318.35M |
| July 30, 2026 | 338.19M |
| July 29, 2026 | 323.93M |
| July 28, 2026 | 304.71M |
| July 27, 2026 | 310.91M |
| July 24, 2026 | 305.95M |
| July 23, 2026 | 312.77M |
| July 22, 2026 | 318.35M |
| July 21, 2026 | 335.71M |
| July 20, 2026 | 274.34M |
| July 17, 2026 | 283.02M |
| July 16, 2026 | 270.00M |
| July 15, 2026 | 237.15M |
| July 14, 2026 | 247.69M |
| July 13, 2026 | 248.93M |
| July 10, 2026 | 259.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Atai Beckley, Inc. | 2.490B |
| Clearmind Medicine, Inc. | -12.42M |
| InMed Pharmaceuticals, Inc. | 5.028M |
| NervGen Pharma Corp. | 156.97M |
| Milestone Pharmaceuticals, Inc. | 85.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -47.82M |
| Total Expenses (Quarterly) | 47.82M |
| EPS Diluted (Quarterly) | -0.914 |
| Earnings Yield | -34.32% |
| Normalized Earnings Yield | -33.07 |